Pharma and Profits
Balancing Innovation, Medicine, and Drug Prices
Wiley · Print & ebook · July 6, 2022
High-level commentary on various facets of the pharmaceutical industry from a key leader in the field This book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices.
We earn from qualifying purchases.
- Who it’s for
- Drug discovery, pricing, and pharmaceutical innovation meet in commentary on industry challenges.
- Genres
- Pharma & Biotech Industry, R&D & Innovation, Pharmacology
- Published
- Wiley, July 6, 2022
Nearest books
Matched by what the books are about, then ordered by what their readers also loved. Most of these share its genre: Pharma & Biotech Industry.
The Philadelphia ChromosomeJessica Wapner, Robert A. Weinberg43% match
The Truth About the Drug CompaniesMarcia Angell65% match
DoctoredCharles Piller56% match
From Breakthrough to BlockbusterDonald L. Drakeman, Lisa N. Drakeman60% match
SickeningJohn Abramson60% match
For Blood and MoneyNathan Vardi60% match
BreakthroughDr William Pao60% matchAlso shares Pharmacology
Basic Principles of Drug Discovery and DevelopmentBenjamin E. Blass, Benjamin Blass58% matchAlso shares Pharmacology
Start with three books, and this one can be the first.
Members get a new edition every morning: a route out from their books to essays, research and talks, with the reason for each.
Start with this bookAbout this book
High-level commentary on various facets of the pharmaceutical industry from a key leader in the field This book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs.
Continue reading
Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: - Fiscal consequences of curing hepatitis C - mRNA vaccines and the race for a cure - Why the government does not deserve a piece of Biopharma’s profits - Paying for drugs whose ultimate value is unknown - The impact of reduced revenues on R&D This book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.
Drug Discovery and Prices
Drug discovery, pricing, and pharmaceutical innovation meet in commentary on industry challenges.
Come here for
- Case studies on hepatitis C
- Commentary on mRNA vaccines and insulin
Expect
- Challenges drug hunters face in developing new drugs
- Questions about paying for drugs whose value is unknown
Where it sits
| Pharma & Biotech Industry | 99% |
|---|---|
| R&D & Innovation | 27% |
| Pharmacology | 20% |
Percentages are BookFrontier’s reading of the book.
Publisher categories
- Pharma & Biotech Industry
- Pharmacology
- Chemistry
- Authors
- John L. LaMattina
- Publisher
- Wiley
- Published
- July 6, 2022
- Format
- Print & ebook
- Reading lane
- Pharma & Biotech Industry